Renalytix Statistics

Total Valuation

Renalytix has a market cap or net worth of GBP 38.09 million. The enterprise value is 43.57 million.

Market Cap	38.09M
Enterprise Value	43.57M

Important Dates

The next estimated earnings date is Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Renalytix has 331.21 million shares outstanding. The number of shares has increased by 27.19% in one year.

Current Share Class	n/a
Shares Outstanding	331.21M
Shares Change (YoY)	+27.19%
Shares Change (QoQ)	-23.50%
Owned by Insiders (%)	15.72%
Owned by Institutions (%)	53.70%
Float	173.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.27
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.08
EV / Sales	24.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.39

Financial Position

The company has a current ratio of 0.24

Current Ratio	0.24
Quick Ratio	0.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.34
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-123.74%
Return on Capital (ROIC)	-501.75%
Revenue Per Employee	17,204
Profits Per Employee	-205,031
Employee Count	102
Asset Turnover	0.19
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.22% in the last 52 weeks. The beta is 1.93, so Renalytix's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	+2.22%
50-Day Moving Average	9.36
200-Day Moving Average	13.57
Relative Strength Index (RSI)	56.52
Average Volume (20 Days)	367,573

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Renalytix had revenue of GBP 1.75 million and -20.91 million in losses. Loss per share was -0.19.

Revenue	1.75M
Gross Profit	223,084
Operating Income	-17.97M
Pretax Income	-20.91M
Net Income	-20.91M
EBITDA	-17.83M
EBIT	-17.97M
Loss Per Share	-0.19

Full Income Statement

Balance Sheet

The company has 678,205 in cash and 6.16 million in debt, giving a net cash position of -5.48 million or -0.02 per share.

Cash & Cash Equivalents	678,205
Total Debt	6.16M
Net Cash	-5.48M
Net Cash Per Share	-0.02
Equity (Book Value)	-8.45M
Book Value Per Share	-0.05
Working Capital	-6.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.24 million and capital expenditures -2,984, giving a free cash flow of -18.24 million.

Operating Cash Flow	-18.24M
Capital Expenditures	-2,984
Free Cash Flow	-18.24M
FCF Per Share	-0.06

Full Cash Flow Statement

Margins

Gross Margin	12.71%
Operating Margin	-1,024.15%
Pretax Margin	-1,191.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Renalytix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.19%
Shareholder Yield	-27.19%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Renalytix has an Altman Z-Score of -80.33. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-80.33
Piotroski F-Score	n/a